760,451 People Completed First Dose of Vaccine... One Additional Death Case After Vaccination Reported

Prime Minister Chung Sye-kyun is receiving the AstraZeneca COVID-19 vaccine at Jongno-gu Public Health Center in Seoul on the 26th. Photo by Kang Jin-hyung aymsdream@

[Asia Economy Reporter Lee Chun-hee] Since the start of COVID-19 vaccinations in South Korea on the 26th of last month, approximately 63% of the priority vaccination group have completed their first dose over the past 28 days.

The COVID-19 Vaccination Response Promotion Team announced on the 26th at midnight that 32,466 new first-dose vaccinations were administered, bringing the total number of people who have completed their first dose to 767,451. Among them, 707,481 received the AstraZeneca vaccine, and 59,970 received the Pfizer vaccine. Including 3,833 people who have received the second dose of the Pfizer vaccine, which has a 3-week interval between the first and second doses, the cumulative number of vaccinated individuals is 771,284.

Breaking down by target groups, among the total 851,126 priority vaccination candidates for the first quarter, 704,893 people completed their first dose out of 769,197 who consented to vaccination, resulting in a vaccination rate of 82.8%.

By vaccination institutions, among 209,383 individuals under 65 in nursing hospitals, 181,092 (86.5%) completed their first dose; in nursing facilities, 99,493 out of 110,892 (89.7%) completed the first dose. COVID-19 first responders accounted for 58,582 (74.4%), hospital-level or higher medical institutions had 305,389 (78.8%), and COVID-19 treatment hospitals had 59,970 (93.7%) who completed their first dose. Among these, 3,833 (6.0%) at COVID-19 treatment hospitals have completed their second dose. Additionally, 367 out of 475 other eligible individuals, such as those traveling abroad for essential purposes, also completed vaccination (77.3%).

Vaccinations for nursing hospital and facility inpatients, residents, and workers aged 65 and older, which began on the 23rd, have been completed by 62,558 out of 376,811 eligible individuals (16.6%). This includes 56,500 in nursing hospitals and 6,058 in nursing facilities.

On the morning of the 17th, vaccination candidates are receiving vaccines at a local vaccination center drill held at the indoor tennis court in Seobuk-gu, Cheonan-si, Chungnam. Photo by Joint Press Corps

Meanwhile, as of midnight on the same day, 103 new cases suspected of adverse reactions following COVID-19 vaccination were reported to health authorities, bringing the total to 10,113 cases.

Among these reports, there was one death. The total number of post-vaccination deaths has now risen to 17. The newly reported death was a woman in her 90s who was hospitalized in a nursing hospital. She passed away the day after receiving the AstraZeneca vaccine on the 23rd, approximately 29 hours later. Authorities stated that the patient had underlying health conditions.

There were three new suspected cases of anaphylaxis, a severe systemic allergic reaction, and one new suspected severe case admitted to the intensive care unit. All four cases involved the AstraZeneca vaccine. The remaining 98 cases involved relatively mild symptoms such as muscle pain, headache, fever, chills, and nausea.

This content was produced with the assistance of AI translation services.